| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $128.4M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2022 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 24,031 | $4.96 | $119,270.66 | +0.9% | -25.3% | -38.6% | |
| Jan 28, 2022 | HROW Harrow, Inc. | 10% Owner | Buy | 6,343 | $6.89 | $43,686.14 | +0.2% | -2.2% | +113.5% | |
| Dec 29, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 11,591 | $6.60 | $76,498.00 | +0.4% | -14.1% | -55.1% | |
| Dec 27, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 38,000 | $6.53 | $248,293.39 | +0.7% | -16.9% | -57.9% | |
| Dec 20, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 703 | $6.49 | $4,562.47 | - | -25.7% | -57.6% | |
| Dec 17, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 10,353 | $6.46 | $66,898.88 | +0.2% | -25.2% | -54.3% | |
| Nov 18, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 24,324 | $6.98 | $169,773.92 | +0.5% | -24.2% | -53.0% | |
| Nov 17, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 25,000 | $4.67 | $116,712.50 | -1.0% | -16.8% | -36.3% | |
| Nov 16, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 15,438 | $4.85 | $74,877.11 | -0.3% | -23.1% | -35.9% | |
| Nov 8, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 220,362 | $6.25 | $1,377,985.53 | -4.2% | -32.7% | -53.7% |